Dow Up0.11% Nasdaq Up0.50%

Synageva BioPharma Corp. (GEVA)

-NasdaqGS
72.17 Up 0.05(0.07%) Aug 29, 4:00PM EDT
|After Hours : 72.18 Up 0.01 (0.01%) Aug 29, 4:45PM EDT
Balance SheetGet Balance Sheet for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Assets
Current Assets
Cash And Cash Equivalents62,137  23,883  60,232  
Short Term Investments346,596  195,070   -  
Net Receivables1,373  2,599  3,451  
Inventory -   -   -  
Other Current Assets6,617  3,555  968  
Total Current Assets 416,723   225,107   64,651  
Long Term Investments -   -   -  
Property Plant and Equipment17,213  4,012  1,256  
Goodwill8,535  8,535  8,535  
Intangible Assets3,491  5,564  8,796  
Accumulated Amortization -   -   -  
Other Assets1,987  38  60  
Deferred Long Term Asset Charges -   -   -  
Total Assets 447,949   243,256   83,298  
Liabilities
Current Liabilities
Accounts Payable13,688  7,688  6,510  
Short/Current Long Term Debt -   -   -  
Other Current Liabilities232  5,391  1,749  
Total Current Liabilities 13,920   13,079   8,259  
Long Term Debt -   -   -  
Other Liabilities3,828   -   -  
Deferred Long Term Liability Charges -   -  991  
Minority Interest -   -   -  
Negative Goodwill -   -   -  
Total Liabilities 17,748   13,079   9,250  
Stockholders' Equity
Misc Stocks Options Warrants -   -   -  
Redeemable Preferred Stock -   -   -  
Preferred Stock -   -   -  
Common Stock31  24  18  
Retained Earnings(254,239)(158,789)(115,840)
Treasury Stock -   -   -  
Capital Surplus684,468  388,936  189,874  
Other Stockholder Equity(59)6  (4)
Total Stockholder Equity 430,201   230,177   74,048  
Net Tangible Assets 418,175   216,078   56,717  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.